<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35139743</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1475-6374</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of enzyme inhibition and medicinal chemistry</Title>
          <ISOAbbreviation>J Enzyme Inhib Med Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inhibition studies of bacterial α-carbonic anhydrases with phenols.</ArticleTitle>
        <Pagination>
          <StartPage>666</StartPage>
          <EndPage>671</EndPage>
          <MedlinePgn>666-671</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/14756366.2022.2038592</ELocationID>
        <Abstract>
          <AbstractText>The α-class carbonic anhydrases (CAs, EC 4.2.1.1) from the bacterial pathogens <i>Neisseria gonorrhoeae</i> (NgCAα) and <i>Vibrio cholerae</i> (VchCAα) were investigated for their inhibition by a panel of phenols and phenolic acids. Mono-, di- and tri-substituted phenols incorporating additional hydroxyl/hydroxymethyl, amino, acetamido, carboxyl, halogeno and carboxyethenyl moieties were included in the study. The best NgCAα inhibitrs were phenol, 3-aminophenol, 4-hydroxy-benzylalcohol, 3-amino-4-chlorophenol and paracetamol, with K<sub>I</sub> values of 0.6-1.7 µM. The most effective VchCAα inhibitrs were phenol, 3-amino-4-chlorophenol and 4-hydroxy-benzyl-alcohol, with K<sub>I</sub> values of 0.7-1.2 µM. Small changes in the phenol scaffold led to drastic effects on the bacterial CA inhibitory activity. This class of underinvestigated bacterial CA inhibitors may thus lead to effective compounds for fighting drug resistant bacteria.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Giovannuzzi</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hewitt</LastName>
            <ForeName>Chad S</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nocentini</LastName>
            <ForeName>Alessio</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-3342-702X</Identifier>
            <AffiliationInfo>
              <Affiliation>Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Capasso</LastName>
            <ForeName>Clemente</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0003-3314-2411</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Agriculture and Food Sciences, CNR, Institute of Biosciences and Bioresources, Napoli, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Costantino</LastName>
            <ForeName>Gabriele</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Food and Drug, University of Parma, Parco Area delle Scienze, Parma, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flaherty</LastName>
            <ForeName>Daniel P</ForeName>
            <Initials>DP</Initials>
            <Identifier Source="ORCID">0000-0002-8305-0606</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Purdue Institute for Drug Discovery, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Purdue Institute of Inflammation, Immunology and Infectious Disease, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Supuran</LastName>
            <ForeName>Claudiu T</ForeName>
            <Initials>CT</Initials>
            <Identifier Source="ORCID">0000-0003-4262-0323</Identifier>
            <AffiliationInfo>
              <Affiliation>Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 AI148523</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Enzyme Inhib Med Chem</MedlineTA>
        <NlmUniqueID>101150203</NlmUniqueID>
        <ISSNLinking>1475-6366</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002257">Carbonic Anhydrase Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010636">Phenols</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 4.2.1.1</RegistryNumber>
          <NameOfSubstance UI="D002256">Carbonic Anhydrases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002257" MajorTopicYN="N">Carbonic Anhydrase Inhibitors</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002256" MajorTopicYN="N">Carbonic Anhydrases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010636" MajorTopicYN="N">Phenols</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014734" MajorTopicYN="N">Vibrio cholerae</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Carbonic anhydrase</Keyword>
        <Keyword MajorTopicYN="N">Neisseria gonorrhoeae</Keyword>
        <Keyword MajorTopicYN="N">Vibrio cholerae</Keyword>
        <Keyword MajorTopicYN="N">antibacterials</Keyword>
        <Keyword MajorTopicYN="N">phenol</Keyword>
      </KeywordList>
      <CoiStatement>CT Supuran is Editor-in-Chief of the Journal of Enzyme Inhibition and Medicinal Chemistry. He was not involved in the assessment, peer review, or decision-making process of this paper. The authors have no relevant affiliations of financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>10</Day>
          <Hour>5</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35139743</ArticleId>
        <ArticleId IdType="pmc">PMC8843131</ArticleId>
        <ArticleId IdType="doi">10.1080/14756366.2022.2038592</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jacob GS, Brown
RD, 3rd, Koenig SH.. 
Interaction of bovine carbonic anhydrase with (neutral) aniline, phenol, and methanol. Biochemistry
1980;19:3754–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6773552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simonsson I, Jonsson BH, Lindskog S.. 
Phenol, a competitive inhibitor of CO2 hydration catalyzed by carbonic anhydrase. Biochem Biophys Res Commun
1982;108:1406–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6817752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nair SK, Ludwig PA, Christianson DW.. 
Two-Site Binding of Phenol in the Active Site of Human Carbonic Anhydrase II: Structural Implications for Substrate Association. J Am Chem Soc
1994;116:3659–60.</Citation>
        </Reference>
        <Reference>
          <Citation>a) Innocenti A, Vullo D, Scozzafava A, Supuran CT.. 
Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Bioorg Med Chem Lett
2008;18:1583–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18242985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Innocenti A, Vullo D, Scozzafava A, Supuran CT.. 
Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem
2008;16:7424–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18242985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Innocenti A, Hilvo M, Scozzafava A, et al. . 
Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett
2008;18:3593–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18242985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Davis RA, Innocenti A, Poulsen SA, Supuran CT.. 
Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library. Bioorg Med Chem
2010;18:14–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19962903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Davis RA, Hofmann A, Osman A, et al. . 
Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases. J Med Chem
2011;54:1682–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19962903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Innocenti A, Gülçin I, Scozzafava A, Supuran CT.. 
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett
2010;20:5050–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20674354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Sarikaya SB, Gülçin I, Supuran CT.. 
Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids. Chem Biol Drug Des
2010;75:515–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20674354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Innocenti A, Beyza Öztürk Sarıkaya S, Gülçin İ, Supuran CT.. 
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem
2010;18:2159–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20674354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekinci D, Kurbanoglu NI, Salamci E, et al. . 
Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds. J Enzyme Inhib Med Chem
2012;27:845–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21999604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Oztürk Sarikaya SB, Topal F, Sentürk M, et al. . 
In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett
2011;21:4259–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21999604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Sentürk M, Gülçin I, Beydemir S, et al. . 
In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des
2011;77:494–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21999604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Carta F, Vullo D, Maresca A, et al. . 
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. Bioorg Med Chem
2013;21:1564–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22668600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Maresca A, Akyuz G, Osman SM, et al. . 
Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters. Bioorg Med Chem
2015;23:7181–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22668600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Burmaoğlu S, Dilek E, Yılmaz AO, Supuran CT.. 
Synthesis of two phloroglucinol derivatives with cinnamyl moieties as inhibitors of the carbonic anhydrase isozymes I and II: an in vitro study. J Enzyme Inhib Med Chem
2016;31:208–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22668600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Ekinci D, Karagoz L, Ekinci D, et al. . 
Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. J Enzyme Inhib Med Chem
2013;28:283–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22168126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Scozzafava A, Passaponti M, Supuran CT, Gülçin İ.. 
Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). J Enzyme Inhib Med Chem
2015;30:586–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22168126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Taslimi P, Gülçin İ, Öztaşkın N, et al. . 
The effects of some bromophenols on human carbonic anhydrase isoenzymes. J Enzyme Inhib Med Chem
2016;31:603–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22168126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a)Karioti A, Ceruso M, Carta F, et al. . 
New natural product carbonic anhydrase inhibitors incorporating phenol moieties. Bioorg Med Chem
2015;23:7219–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26498393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Karioti A, Carta F, Supuran CT.. 
Phenols and Polyphenols as Carbonic Anhydrase Inhibitors. Molecules
2016;21:1649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26498393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Cau Y, Mori M, Supuran CT, Botta M.. 
Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations. Org Biomol Chem
2016;14:8322–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26498393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Carreyre H, Coustard JM, Carré G, et al. . 
Natural product hybrid and its superacid synthesized analogues: dodoneine and its derivatives show selective inhibition of carbonic anhydrase isoforms I, III, XIII and XIV. Bioorg Med Chem
2013;21:3790–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23685174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Carre G, Ouedraogo M, Magaud C, et al. . 
Vasorelaxation induced by dodoneine is mediated by calcium channels blockade and carbonic anhydrase inhibition on vascular smooth muscle cells. J Ethnopharmacol
2015;169:8–17. Jul 1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23685174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Carreyre H, Carré G, Ouedraogo M, et al. . 
Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca2+ Current Inhibitors for Hypotensive Agent Discovery. Molecules
2017;22:915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23685174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Riafrecha LE, Vullo D, Ouahrani-Bettache S, et al. . 
Inhibition of β-carbonic anhydrases from Brucella suis with C-cinnamoyl glycosides incorporating the phenol moiety. J Enzyme Inhib Med Chem
2015;30:1017–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25676329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Riafrecha LE, Bua S, Supuran CT, Colinas PA.. 
Improving the carbonic anhydrase inhibition profile of the sulfamoylphenyl pharmacophore by attachment of carbohydrate moieties. Bioorg Chem
2018;76:61–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25676329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Nocentini A, Bonardi A, Gratteri P, et al. . 
Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms. J Enzyme Inhib Med Chem
2018;33:1453–9. Dec</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7011995</ArticleId>
            <ArticleId IdType="pubmed">30221552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Yamali C, Gul HI, Sakagami H, Supuran CT.. 
Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases. J Enzyme Inhib Med Chem
2016;31:125–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7011995</ArticleId>
            <ArticleId IdType="pubmed">30221552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Inci Gul H, Yamali C, Tugce Yasa A, et al. . 
Carbonic anhydrase inhibition and cytotoxicity studies of Mannich base derivatives of thymol. J Enzyme Inhib Med Chem
2016;31:1375–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7011995</ArticleId>
            <ArticleId IdType="pubmed">30221552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Entezari Heravi Y, Bua S, Nocentini A, et al. . 
Inhibition of Malassezia globosa carbonic anhydrase with phenols. Bioorg Med Chem
2017;25:2577–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28343756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Nocentini A, Bua S, Del Prete S, et al. . 
Natural polyphenols selectively inhibit β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa: activity and modeling studies. Chem Med Chem
2018;13:816–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28343756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Paloukopoulou C, Govari S, Soulioti A, et al. . 
Phenols from Origanum dictamnus L. and Thymus vulgaris L. and their activity against Malassezia globosa carbonic anhydrase. Nat Prod Res
2022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28343756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Nocentini A, Osman SM, Del Prete S, et al. . 
Extending the γ-class carbonic anhydrases inhibition profiles with phenolic compounds. Bioorg Chem
2019;93:103336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31604186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Alissa SA, Alghulikah HA, ALOthman ZA, et al. . 
Inhibition survey with phenolic compounds against the δ- and η-class carbonic anhydrases from the marine diatom Thalassiosira weissflogii and protozoan Plasmodium falciparum. J Enzyme Inhib Med Chem
2020;35:377–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31604186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grande R, Carradori S, Puca V, et al. . 
Selective inhibition of helicobacter pylori carbonic anhydrases by carvacrol and thymol could impair biofilm production and the release of outer membrane vesicles. Int J Mol Sci
2021;22:11583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8584244</ArticleId>
            <ArticleId IdType="pubmed">34769015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Andring J, Combs J, McKenna R.. 
Aspirin: a suicide inhibitor of carbonic anhydrase II. Biomolecules
2020;10:527.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7226357</ArticleId>
            <ArticleId IdType="pubmed">32244293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) D'Ambrosio K, Carradori S, Cesa S, et al. . 
Catechols: a new class of carbonic anhydrase inhibitors. Chem Commun (Camb)
2020;56:13033–6. Nov 4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7226357</ArticleId>
            <ArticleId IdType="pubmed">32244293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Nocentini A, Angeli A, Carta F, et al. . 
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem
2021;36:561–80. Dec</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7901698</ArticleId>
            <ArticleId IdType="pubmed">33615947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Supuran CT.
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov
2008;7:168–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7901698</ArticleId>
            <ArticleId IdType="pubmed">33615947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Mishra CB, Tiwari M, Supuran CT.. 
Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?
Med Res Rev
2020;40:2485–565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7901698</ArticleId>
            <ArticleId IdType="pubmed">33615947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Supuran CT.
Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem
2012;27:759–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22468747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Supuran CT.
How many carbonic anhydrase inhibition mechanisms exist?
J Enzyme Inhib Med Chem
2016;31:345–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22468747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Supuran CT.
Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?
Front Pharmacol
2011;2:34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3132667</ArticleId>
            <ArticleId IdType="pubmed">21779249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Flaherty DP, Seleem MN, Supuran CT.. 
Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem
2021;13:1619–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3132667</ArticleId>
            <ArticleId IdType="pubmed">21779249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Petreni A, De Luca V, Scaloni A, et al. . 
Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem
2021;36:372–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3132667</ArticleId>
            <ArticleId IdType="pubmed">21779249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>d) Supuran CT, Capasso C.. 
An Overview of the Bacterial Carbonic Anhydrases. Metabolites
2017;7:56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3132667</ArticleId>
            <ArticleId IdType="pubmed">21779249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Supuran CT, Capasso C.. 
Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat
2018;28:745–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29973089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Supuran CT, Capasso C.. 
Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Expert Opin Ther Pat
2020;30:963–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29973089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Hewitt CS, Abutaleb NS, Elhassanny AEM, et al. . 
Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae. ACS Infect Dis
2021;7:1969–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29973089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>d) Nocentini A, Hewitt CS, Mastrolorenzo MD, et al. . 
Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem
2021;36:1061–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29973089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>e) Giovannuzzi S, Hewitt CS, Nocentini A, et al. . 
Coumarins effectively inhibit bacterial α-carbonic anhydrases. J Enzyme Inhib Med Chem
2022;37:333–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29973089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Kaur J, Cao X, Abutaleb NS, et al. . 
Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant enterococcus. J Med Chem
2020;63:9540–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Abutaleb NS, Elkashif A, Flaherty DP, Seleem MN.. 
In vivo antibacterial activity of acetazolamide. Antimicrob Agents Chemother
2021;65:e01715–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Abutaleb NS, Elhassanny AEM, Flaherty DP, Seleem MN.. 
In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ
2021;9:e11059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>d) Giovannuzzi S, Abutaleb NS, Hewitt CS, et al. . 
Dithiocarbamates effectively inhibit the α-carbonic anhydrase from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem
2022;37:1–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>e) Abutaleb NS, Elhassanny AEM, Nocentini A, et al. . 
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae. J Enzyme Inhib Med Chem
2022;37:51–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalifah RG.
The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem
1971;246:2561–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4994926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Del Prete S, Isik S, Vullo D, et al. . 
DNA cloning, characterization, and inhibition studies of an α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J Med Chem
2012;55:10742–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23181552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Del Prete S, De Luca V, Scozzafava A, et al. . 
Biochemical properties of a new α-carbonic anhydrase from the human pathogenic bacterium, Vibrio cholerae. J Enzyme Inhib Med Chem
2014;29:23–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23181552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Angeli A, Del Prete S, Osman SM, et al. . 
Activation studies of the α- and β-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with amines and amino acids. J Enzyme Inhib Med Chem
2018;33:227–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23181552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>a) Maduna LD, Peters RPH, Kingsburgh C, et al. . 
Antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium isolates from the private healthcare sector in South Africa: A pilot study. S Afr Med J
2021;111:995–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34949296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>b) Kueakulpattana N, Wannigama DL, Luk-In S, et al. . 
Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. Sci Rep
2021;11:21659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34949296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>c) Barbee LA.
New evidence for antimicrobial-resistant gonorrhea control programs: lessons learned from the SURRG project. Sex Transm Dis
2021;48:S93–S96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34949296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Simone G, Bua S, Supuran CT, Alterio V.. 
Benzyl alcohol inhibits carbonic anhydrases by anchoring to the zinc coordinated water molecule. Biochem Biophys Res Commun
2021;548:217–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33647799</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
